Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Research & Development: 2010-2012

Historic Research & Development for Sonoma Pharmaceuticals (SNOA) over the last 3 years, with Dec 2012 value amounting to $509,000.

  • Sonoma Pharmaceuticals' Research & Development changed negligibly% to $509,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $2.0 million, marking a year-over-year decrease of 4.92%. This contributed to the annual value of $2.0 million for FY2012, which is 3.18% down from last year.
  • According to the latest figures from Q4 2012, Sonoma Pharmaceuticals' Research & Development is $509,000, which was down 0.78% from $513,000 recorded in Q3 2012.
  • Sonoma Pharmaceuticals' Research & Development's 5-year high stood at $630,000 during Q1 2011, with a 5-year trough of $396,000 in Q2 2010.
  • Moreover, its 3-year median value for Research & Development was $509,000 (2012), whereas its average is $507,364.
  • Data for Sonoma Pharmaceuticals' Research & Development shows a peak YoY increase of 22.02% (in 2012) and a maximum YoY decrease of 24.44% (in 2012) over the last 5 years.
  • Sonoma Pharmaceuticals' Research & Development (Quarterly) stood at $467,000 in 2010, then grew by 8.99% to $509,000 in 2011, then remained steady at $509,000 in 2012.
  • Its last three reported values are $509,000 in Q4 2012, $513,000 for Q3 2012, and $532,000 during Q2 2012.